The GeoVax Labs (Nasdaq: GOVX) story is no longer just about viruses; it is now also about a stage, a microphone, and a very focused webinar based room of investors at Tribe Public’s CEO Presentation and Q&A Event, which took place earlier…
Vista Partners’ sister organization Tribe Public www.tribepublic.com is once again turning a high‑stakes public health story into a conversation, this time by putting hemorrhagic fevers and vaccine preparedness squarely on the calendar for May 28, 2026 at 8am pacific time via their…
Eli Lilly’s (LLY) latest vaccine shopping spree and GeoVax Labs’s (GOVX) sharpened strategic focus together seemingly sketch a quietly bullish subplot in an otherwise noisy biotech market, giving investors a fresh angle on infectious disease and immuno-oncology risk-on exposure.
Big Pharma…
The United States is quietly tightening its Ebola defenses, and this time Atlanta’s massive air hub and a small vaccine developer based in Atlanta named GeoVax Labs (NASDAQ: GOVX) are sharing the spotlight in a story that is more about preparedness than…
A new Ebola outbreak in Congo is once again testing global health systems, but it is also spotlighting a small group of vaccine developers who have spent the quiet years preparing for noisy ones like this. As health agencies scramble on the…